Your search for major depressive disorder returned 36 results

A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.

The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.

Given the ethnic and racial disparities in the US, researchers examined whether SDoH contributed to racial and ethnic disparities in cognition, health, and depression.

Investigators assessed the prevalence of exposure to medications with potential drug-drug interactions to ritonavir-containing COVID-19 therapy among US adults.

In a systematic literature review, researchers determined the global prevalence of head trauma among refugees and asylum seekers and described its common clinical characteristics in this population.

Psilocybin treatment in a community setting appears safe and effective for patients with cancer and depression.

Patients with and without ADHD were recruited for this cross-sectional, pragmatic, observational study.

Investigators searched publication databases for studies of depression among perinatal women on the basis of country income status.

A study was conducted to determine the effects of switching or augmenting antidepressant therapy in adults with treatment-resistant depression.

Patients with MDD were randomly assigned in a 1:1:1 ratio to receive 1.5 mg daily cariprazine, 3.0 mg daily cariprazine, or placebo for 6 weeks.

Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.

Researcher sought to assess how timing, frequency, and maintenance of physical activity in adulthood, over the span of 30 years, is associated with cognitive function later in life.

Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.

According to a new poll, more than 90% of adults who reported they get good sleep were also free of depressive symptoms.

Being physically active at any point during adulthood is associated with a higher later-life cognitive state.

Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.

Authors say findings similar across people with schizophrenia, major depressive disorder, and bipolar disorder in three distinct geographic settings

Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.

Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.

Better baseline cardiovascular health and improvement in cardiovascular health over seven years tied to lower 19-year risk for depression

The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.

The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.

Investigators sought to assess associations for US Army soldiers bullied by fellow soldiers with mental health outcomes.

Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.

Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.

Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.

American College of Physicians recommends monotherapy with cognitive therapy or second-generation antidepressant for patients in acute phase of moderate-to-severe depression

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

Investigators aimed to evaluate the efficacy of combined treatment (antidepressants plus STPP) vs antidepressants (with or without brief supportive psychotherapy) on depressive symptoms in adults in acute-phase depression.

However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder